Clinical Trial Update: Effects of Amlodipine/Benazepril in Reducing Left Ventricular Hypertrophy in Patients With High Risk Hypertension [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating whether the combination of amlodipine and benazepril reduces left ventricular hypertrophy in patients with high-risk hypertension; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Left Ventricular Hypertrophy

Drugs mentioned

• Amlodipine (amlodipine)
• Benazepril (Benazepril)
• LOTREL (amlodipine besylate and benazepril hydrochloride)

Snippet

Sponsor: Novartis | Conditions: Hypertension, Left Ventricular Hypertrophy | Phase 4 | Status: COMPLETED